dihydrotestosterone has been researched along with Osteoporosis, Postmenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WY; Lau, TL; Long, YO; López, FJ; Marschke, KB; Martinborough, E; Negro-Vilar, A; Oeveren, Av; Rix, PJ; Shen, Y; Vajda, EG; Viveros, OH; Zhi, L | 1 |
| Dalton, JT; Fisher, SJ; Gao, W; Kearbey, JD; Miller, DD; Narayanan, R; Wu, D | 1 |
2 other study(ies) available for dihydrotestosterone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
Topics: Administration, Oral; Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Biological Availability; Bone Density Conservation Agents; Female; Humans; Hypogonadism; Male; Muscle, Skeletal; Organ Size; Osteoporosis, Postmenopausal; Prostate; Pyrrolidines; Quinolines; Quinolones; Rats; Stereoisomerism; Structure-Activity Relationship | 2007 |
Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats.
Topics: Absorptiometry, Photon; Acetamides; Adiposity; Aminophenols; Animals; Biomechanical Phenomena; Body Composition; Body Weight; Bone Density; Bone Density Conservation Agents; Cell Differentiation; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Humans; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Androgen | 2007 |